Доступ предоставлен для: Guest
Critical Reviews™ in Oncogenesis
Главный редактор: Benjamin Bonavida (open in a new tab)

Выходит 4 номеров в год

ISSN Печать: 0893-9675

ISSN Онлайн: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis

Том 22, Выпуск 1-2, 2017, pp. 23-36
DOI: 10.1615/CritRevOncog.2017020836
Get accessGet access

Краткое описание

Despite significant clinical and basic science advancements, cancer remains a devastating disease that affects people of all ages, races, and backgrounds. The pathogenesis of cancer has recently been described to result from eight biological capabilities or hallmarks and two enabling characteristics. These eight hallmarks are: deregulation of cellular energetics, avoiding immune destruction, enabling replicative immortality, inducing angiogenesis, sustaining proliferative signaling, evading growth suppressors, resisting cell death, and activating invasion and metastasis. The enabling characteristics are: genome instability and mutation and tumor-promoting inflammation. Survivin, the fourth most common transcript found in cancer cells, is a protein that is thought to be involved in the enhanced proliferation, survival, and metastasis and possibly other key hallmarks of cancer cells. Understanding how this gene is turned on and off is vitally important for attempt improving cancer management and therapy. Our work has identified a novel transcriptional regulator of survivin called Yin Yang 1 (YY1), which has been observed to activate some gene promoters and repress others and is gaining increasing interest as a target of cancer therapy. Our work shows for the first time that YY1 represses survivin transcription by physically interacting with the survivin promoter. Furthermore, YY1 appears to contribute to basal survivin transcriptional activity, indicating that disruption of its binding may in part contribute to survivin overexpression after cellular stress events including chemotherapy and radiotherapy.

Ключевые слова: survivin, YY1, metastasis, cancer, transcription factor
ЦИТИРОВАНО В
  1. Yang Tingting, Shu Fanglin, Yang Hao, Heng Cai, Zhou Yi, Chen Yibing, Qian Xuan, Du Lei, Zhu Xia, Lu Qian, Yin Xiaoxing, YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis, Metabolism, 96, 2019. Crossref

  2. Chen Qun, Yang Chuang, Chen Lei, Zhang Jing-Jing, Ge Wan-Li, Yuan Hao, Meng Ling-Dong, Huang Xu-Min, Shen Peng, Miao Yi, Jiang Kui-Rong, YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways, British Journal of Cancer, 121, 11, 2019. Crossref

  3. Turton Kristi L., Meier-Stephenson Vanessa, Badmalia Maulik D., Coffin Carla S., Patel Trushar R., Host Transcription Factors in Hepatitis B Virus RNA Synthesis, Viruses, 12, 2, 2020. Crossref

  4. Scarpa Emanuele Salvatore, Tasini Filippo, Crinelli Rita, Ceccarini Chiara, Magnani Mauro, Bianchi Marzia, The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells, International Journal of Molecular Sciences, 21, 15, 2020. Crossref

  5. Vivarelli Silvia, Falzone Luca, Ligresti Giovanni, Candido Saverio, Garozzo Adriana, Magro Gaetano Giuseppe, Bonavida Benjamin, Libra Massimo, Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets, International Journal of Molecular Sciences, 21, 17, 2020. Crossref

  6. Chen Li, Fan Xiao-Di, Qu Hua, Bai Rui-Na, Shi Da-Zhuo, Yong Yoke Keong, Berberine Protects against TNF-α-Induced Injury of Human Umbilical Vein Endothelial Cells via the AMPK/NF-κB/YY1 Signaling Pathway, Evidence-Based Complementary and Alternative Medicine, 2021, 2021. Crossref

  7. Chen Qun, Wang Wu-Jun, Jia Yun-Xuan, Yuan Hao, Wu Peng-Fei, Ge Wan-Li, Meng Ling-Dong, Huang Xu-Min, Shen Peng, Yang Tao-Yue, Miao Yi, Zhang Jing-Jing, Jiang Kui-Rong, Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review, Cell & Bioscience, 11, 1, 2021. Crossref

  8. Zhou Shuai, Qu Kang Lin, Li Jin Ang, Chen Shi Lei, Zhang Yi Gang, Zhu Chao, Jin Hao, Wang Yong, Pang Qing, Liu Hui Chun, YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis, Cancer Cell International, 21, 1, 2021. Crossref

  9. Li Yuming, Lu Wenshu, Yang Jiarun, Edwards Mark, Jiang Shisong, Survivin as a biological biomarker for diagnosis and therapy, Expert Opinion on Biological Therapy, 21, 11, 2021. Crossref

  10. Fu Xinghao, Ji Feihong, He Qi, Qiu Xinguang, Wang Fu, A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets, Journal of Immunology Research, 2022, 2022. Crossref

  11. Zhang Shuya, Kim Ji Young, Xu Suowen, Liu Huan, Yin Meimei, Koroleva Marina, Guo Jia, Pei Xiuying, Jin Zheng Gen, Endothelial-specific YY1 governs sprouting angiogenesis through directly interacting with RBPJ, Proceedings of the National Academy of Sciences, 117, 9, 2020. Crossref

  12. Fuller Ryan N, Kabagwira Janviere, Vallejos Paul A, Folkerts Andrew D, Wall Nathan R, Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine, OncoTargets and Therapy, Volume 15, 2022. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain